Boothbay Fund Management, LLC Gilead Sciences, Inc. Transaction History

Boothbay Fund Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $5.87 Million - $6.69 Million	75,972 Added 107.25%	146,807 $12.2 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $4.41 Million - $6.34 Million	70,835 New	70,835 $6.08 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $287,618 - $323,944	4,983 New	4,983 $308,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $401,607 - $455,831	-6,190 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $6,565 - $7,083	-97 Reduced 1.54%	6,190 $432,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $518,042 - $566,034	-8,162 Reduced 56.49%	6,287 $433,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $400,440 - $456,902	6,674 Added 85.84%	14,449 $934,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $440,453 - $501,876	7,775 New	7,775 $453,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $933,186 - $1.08 Million	-12,900 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $807,927 - $1.03 Million	12,900 New	12,900 $964,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $224,274 - $273,415	-3,079 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $219,070 - $257,158	3,079	3,079 $221,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.